Cite

HARVARD Citation

    Hao, C. et al. (2017). Efficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma. Medicine. 96 (26), p. . [Online]. 
  
Back to record